NervGen Pharma Corp.

DB:9UA Stock Report

Market Cap: €107.5m

NervGen Pharma Corp. Company Information

NervGen Pharma Corp.'s employee growth, exchange listings and data sources

Key Information

  • Name: NervGen Pharma Corp.
  • Ticker: 9UA
  • Exchange: DB
  • Founded: 2017
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CA$157.378m
  • Listing Market Cap: CA$107.486m
  • Shares Outstanding: 70.26m
  • Website: https://www.nervgen.com

Number of Employees

Location

  • NervGen Pharma Corp.
  • 112-970 Burrard Street
  • Unit 1290
  • Vancouver
  • British Columbia
  • V6Z 2R4
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NGENTSXV (TSX Venture Exchange)YesCommon SharesCACADMar 2019
NGEN.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDMar 2019
9UADB (Deutsche Boerse AG)YesCommon SharesDEEURMar 2019

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/21 04:04
End of Day Share Price 2024/11/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.